About Cellnovo
Cellnovo is a company based in London (United Kingdom) founded in 2002. It operates as a B2C. Cellnovo has raised $48.4 million across 3 funding rounds from investors including Crédit Agricole, Edmond de Rothschild and Kreos Capital. Cellnovo offers products and services including Slot Games Platform and Mobile App. Cellnovo operates in a competitive market with competitors including Admetsys, TypeZero Technologies, Pacific Diabetes Technologies, Ideal Medical Technologies and Animas, among others.
- Headquarter London, United Kingdom
- Stage Public
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cellnovo Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.4 M (USD)
in 3 rounds
-
Latest Funding Round
$5.5 M (USD), Debt – Conventional
May 10, 2017
-
Investors
Crédit Agricole
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellnovo
Cellnovo offers a comprehensive portfolio of products and services, including Slot Games Platform and Mobile App.
Provides digital slot games with bonuses for user entertainment.
App for downloading and accessing slot games directly.
Funding Insights of Cellnovo
Cellnovo has successfully raised a total of $48.4M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5.5 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellnovo
Cellnovo has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Crédit Agricole, Edmond de Rothschild and Kreos Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on lifescience and healthcare sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cellnovo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellnovo
Investment portfolio details for Cellnovo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellnovo
Detailed financials for Cellnovo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellnovo Comparisons
Peer comparison for Cellnovo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellnovo
Cellnovo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Admetsys, TypeZero Technologies, Pacific Diabetes Technologies, Ideal Medical Technologies and Animas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a closed-loop system for insulin and glucose delivery
|
|
| Locked | Locked | Locked |
Device for continuous glucose monitoring with manually operated insulin delivery
|
|
| Locked | Locked | Locked |
Electronic diabetes management device for glucose sensing and hormone delivery
|
|
| Locked | Locked | Locked |
An AI-based artificial pancreas system is developed for ICU patients.
|
|
| Locked | Locked | Locked |
Device for continuous glucose monitoring with manual insulin administration
|
Detailed competitors of Cellnovo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellnovo
Complete news archive for Cellnovo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellnovo
Cellnovo was founded in 2002 and raised its 1st funding round 9 years after it was founded.
Cellnovo is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Cellnovo is a funded company, having raised a total of $48.4M across 3 funding rounds to date.
SALAKTOTO functions as an online platform providing various modern slot games focused on entertainment and potential winnings. It features an easy-to-use interface with bonuses and promotions to enhance user engagement. The site emphasizes security and high win rates, attracting players in the digital gaming space. While associated with broader e-commerce elements, its core is gaming services without specified locations or clients.
Cellnovo's top competitors include Admetsys, TypeZero Technologies and Ideal Medical Technologies.
Cellnovo offers Slot Games Platform and Mobile App.
Cellnovo has 11 investors. Key investors include Crédit Agricole, Edmond de Rothschild, Kreos Capital, European Union, and Forbion.